AG
TGTX icon

Algert Global’s TG Therapeutics TGTX Stock Holding History

Algert Global’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.41M Sell
62,121
-39,360
-39% -$1.61M 0.04% 689
2026
Q1 		$3.37M Sell
101,481
-383,711
-79% -$11.4M 0.05% 561
2025
Q4 		$14.5M Buy
485,192
+402,821
+489% +$13.2M 0.23% 103
2025
Q3 		$2.98M Buy
82,371
+14,290
+21% +$471K 0.05% 561
2025
Q2 		$2.45M Sell
68,081
-8,960
-12% -$334K 0.05% 569
2025
Q1 		$3.04M Buy
77,041
+27,980
+57% +$941K 0.08% 455
2024
Q4 		$1.48M Sell
49,061
-55,191
-53% -$1.58M 0.03% 704
2024
Q3 		$2.44M Sell
104,252
-42,966
-29% -$938K 0.07% 494
2024
Q2 		$2.62M Buy
147,218
+97,118
+194% +$1.55M 0.09% 380
2024
Q1 		$762K Sell
50,100
-970
-2% -$15.5K 0.03% 684
2023
Q4 		$872K Sell
51,070
-5,590
-10% -$65K 0.04% 656
2023
Q3 		$474K Sell
56,660
-43,271
-43% -$603K 0.02% 760
2023
Q2 		$2.48M Buy
99,931
+63,351
+173% +$1.64M 0.11% 325
2023
Q1 		$550K Sell
36,580
-150,449
-80% -$2.29M 0.03% 797
2022
Q4 		$2.21M Buy
187,029
+78,720
+73% +$571K 0.12% 265
2022
Q3 		$641K Buy
108,309
+8,639
+9% +$56.7K 0.04% 726
2022
Q2 		$424K Buy
+99,670
New +$622K 0.03% 810
2021
Q1 		– Sell
-12,208
Closed -$635K – 530
2020
Q4 		$635K Buy
+12,208
New +$412K 0.18% 183

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Algert Global's TGTX Position: Q2 2026 in Review

Algert Global reduced its TG Therapeutics (TGTX) stake by 39% in Q2 2026, selling an estimated $1.61M and leaving 62,121 shares worth $3.41M. The position accounts for 0.04% of the portfolio, ranked #689.

Algert Global first reported a position in TGTX in Q4 2020 and has held it in 18 quarters since. The position peaked at $14.5M in Q4 2025. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Algert Global held 62,121 shares of TG Therapeutics worth $3.41M as of Q2 2026.
  • Algert Global sold 39,360 TG Therapeutics shares in Q2 2026, an estimated $1.61M.
  • TG Therapeutics made up 0.04% of Algert Global's portfolio in Q2 2026, its #689 holding.
  • Algert Global first reported a position in TG Therapeutics in Q4 2020 and has held it in 18 quarters since.
  • Algert Global's TG Therapeutics position peaked at $14.5M in Q4 2025.
  • 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.